ExoCoBio’s merchandise, incorporating exosomes derived from rose stem cells, promote anti-inflammation and regeneration in pores and skin and scalp by way of its ExoSCRT expertise. As a part of its world growth, ExoCoBio has recognized India as a key market with potential as a consequence of its numerous client base and growing demand for modern skincare options.
The model is launching the ASCEplus vary of skincare and haircare options in India, which incorporates merchandise just like the Soothing Gel Masks, Exobalm, Scalp Rejuvenation Answer amongst many others. Of those, the ASCEplus SRLV and ASCEplus HRLV formulations are tailor-made to be used by dermatologists, plastic surgeons, aesthetic practitioners, premium skincare clinics and medispas wanting to supply these revolutionary regenerative aesthetic options. However, the Soothing Gel Masks and Exobalm are at dwelling use merchandise.
India’s quickly rising skincare market, growing client consciousness, and rising demand for superior options make it a strategically vital marketplace for ExoCoBio. After years of looking for the proper distributorship and assessing the market dynamics, we’re proud to announce its entry into India in collaboration with Chief Medical Programs, the official distributor of the ASCEplus model.
We intention to ascertain ASCEplus merchandise as a market chief, educate professionals and shoppers, and construct a long-term presence in a market poised for exponential development. The corporate expects India to grow to be a crucial pillar in its world growth technique and a key contributor to its total success.
Q. Are you able to clarify the idea of exosome-based skincare and its benefits over conventional skincare?
Exosome-based skincare represents a revolutionary development over conventional strategies. Exosomes are key signaling molecules between cells in a human physique. By working on the mobile degree and addressing root causes of pores and skin growing older and harm, it presents extra complete, long-lasting, and transformative outcomes.
Combining exosomes with different elements successfully to create a ultimate product that delivers outcomes and is commercially viable. Exosomes are nice and perhaps one of the best bio-material naturally generated. They ship messages and act as triggers to provoke a pure regenerative course of within the physique. With extra elements, we created synergistic results for higher and quicker medical advantages, enhancing the pure properties of exosomes.
Q. How does ExoCoBio plan to bridge the hole between aesthetic and medical purposes within the skincare trade?
Once I based ExoCoBio, my imaginative and prescient was to fill an unmet want inside our world ageing inhabitants. Current remedies like botulinum toxins, dermal fillers, and energy-based gadgets aren’t all the time appropriate for pores and skin regeneration and reversing pores and skin ageing. Contemplating this hole, my aim was to pioneer a brand new strategy: regenerative aesthetics and regenerative medication remedies that would doubtlessly reverse sure facets of ageing.
Our modern resolution, based mostly on stem cell-derived exosomes, holds vital promise for treating intractable pores and skin situations comparable to dermatitis, psoriasis, scleroderma, and pores and skin fibrosis. These exosomes have a twin synergistic operate of regeneration and anti-inflammation, making them a strong device within the area of dermatology.
Q. How has the model’s worldwide expertise formed its strategy to coming into the Indian market?
As a dedicated world chief, ExoCoBio has made the most important funding in science, expertise, GMP manufacturing, and enterprise, totalling about $80 million over the previous seven years. We strived to cowl and develop new applied sciences and modern protocols/modalities for all pores and skin and dermatological purposes, resulting in 73 registered patents worldwide. We anticipate extra over time. As of December 2025, our merchandise have been delivered to about 2 million sufferers throughout 50+ international locations, supported by 17,000 clinics and practitioners who belief our exosome applied sciences.
The corporate has already established a presence in additional than 50 international locations together with main markets comparable to USA, China, Europe, Brazil, Russia and and so forth. This expertise permits us to penetrate Indian market replicating our partnerships with premium distributors and clinics, which labored efficiently in different markets. ExoCoBio understands the rising demand in India for brand spanking new class in medical aesthetics based mostly on exosomes that aligns with developments seen globally.
Q. Will worth be a ache level given how worth delicate the Indian market is?
Whereas worth sensitivity poses a problem within the Indian market, it may be successfully addressed by emphasizing the unrivaled worth and confirmed efficacy of ASCEplus. ExoCoBio’s world success story, with operations efficiently established in additional than 50 international locations worldwide, reinforces its capacity to ship modern and efficient skincare options. By way of focused schooling, trusted partnerships with professionals, and a give attention to delivering premium worth, we’re assured in its capacity to increase its footprint in India and additional strengthen its world management in exosome-based skincare.
Q. What are ExoCoBio’s long-term objectives in India, and the way do you propose to increase your footprint within the nation?
ExoCoBio goals to ascertain itself as a premier model in India, similar to its standing in different areas just like the US, Europe, and South America. The corporate will give attention to constructing its status as a essentially the most scientifically validated exosome expertise on this planet.
We plan to associate with main dermatology clinics, plastic surgeons, and medical spas throughout main key Indian cities to advertise its ASCEplus merchandise. Firm may also work to make its exosome-based homecare merchandise extra accessible to a wider viewers in India, together with each professionals and shoppers. The aim is to have its ASCE homecare merchandise out there at main aesthetic clinics and hospitals throughout the nation.
Byong Cho, CEO and CTO of ExoCoBio